SCHEMBL6243149

SCHEMBL6243149

O=C(CNc1cccc(Cl)c1)Oc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
MAPT P10636 4/20 0.50
HTT P42858 3/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 2/20 0.50
FAAH O00519 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
ALDH1A1 P00352 3/20 0.46
TP53 P04637 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
GRK2 P25098 2/20 0.43
GRK3 P35626 2/20 0.43
ROCK2 O75116 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6243396 0.84 CYP19A1 (0.46) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL23771128 0.82 MTNR1A (0.56) MEN1KMT2ANPC1RAB9AHTT
SCHEMBL7593370 0.81 MEN1 (0.51) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL11667343 0.81 MEN1 (0.46) MEN1KMT2ANPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL15646288 0.80 MEN1 (0.50) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL6239200 0.79 KMT2A (0.47) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL30421886 0.79 MEN1 (0.56) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL157003 0.79 MEN1 (0.56) MEN1KMT2ANPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL30605752 0.79 MEN1 (0.56) MEN1KMT2ANPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL28590040 0.79 MEN1 (0.56) MEN1KMT2ANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-B1 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL INC (US) 2005-06-29 EP disclosed